TheNews

July 10, 2015

Brain Canada congratulates Dr. Sandra Black who was named Officer of the Order of Canada “for contributing to improved diagnosis and treatment of vascular dementia, Alzheimer’s disease and stroke”. Dr Black is senior scientist at the Sunnybrook Research Institute in Toronto.

The Investiture Ceremony took place July 1st, 2015 in Ottawa, in the presence of the Governor General of Canada. The Order of Canada was created to recognize outstanding achievement, dedication to the community and service to the nation.

NeuroDevNet and Brain Canada (through the Canada Brain Research Fund) are happy to announce a competition for studentships in developmental neurosciences valued at up to $30,000 per year for a maximum funding term of two years, and postdoctoral fellowships valued at up to $50,000 per year for a maximum funding term of two years. All awards include an additional $5,000 per year career development supplement. In addition, all awardees will be required to attend the NeuroDevNet Annual Brain Development Conference as well as training courses and workshops organized through the NeuroDevNet Training Program.

Everyone at Brain Canada is heartbroken over the sudden death of Barbara Turnbull. She was a source of great inspiration. She was a constant reminder that patients must be at the center of research, and that every discovery along the way to a cure carries the potential of improving lives.

Barb brought joy and optimism to all among us who had the privilege of knowing her. She made our lives better. She made us better.

She will be missed beyond words. Our thoughts and prayers are with her devoted and loving family.

RBC-Brain Canada Research Partnership in Mental Health Services for Children and YouthMulti-Investigator Research Initiative (MIRI)Request for Applications

The RBC – Brain Canada Research Partnership will support a multi-investigator three-year research project focused on improved delivery of mental health services through the identification and validation of innovative interventions and practices that are cost-effective, and delivered at the right place and time to support both affected individuals and their families. Notably, the funded project will involve a continuing collaboration between researchers, policy-makers, service providers, and those affected by child and youth mental health issues. The collaboration will jointly identify the research questions to be studied, be engaged in the research project itself, and cooperate in the dissemination of the projects' findings to influence policy and practice.

The deadline for the receipt of letters of intent has been extended from Apr 3, 2015 to Apr 7, 2015

Click here to view the Request for Application and here to submit a Letter of Intent (LOI)

ALS Canada and Brain Canada wish to announce the 2015 funding opportunities resulting from their landmark $20 million partnership. The objective of this joint funding program is to support research that is relevant to ALS and related neurological disorders, including primary lateral sclerosis, progressive muscular atrophy, and ALS/FTLD (ALS/frontotemporal lobar dementia). The ultimate goal of the ALS Society of Canada and Brain Canada is to prevent or cure these disorders, to slow their progression, and to improve the quality of life for those affected and their families.

From left to right: Inez Jabalpurwala, President and CEO of Brain Canada; Dr. Janet Rossant, Chief of Research, The Hospital for Sick Children; Dr. Uri Tabori, researcher and recipient of a grant, The Hospital for Sick Children; Honourable Minister Rona Ambrose, Health Minister of Canada; Dr. Michael Taylor, researcher and recipient of a grant, The Hospital for Sick Children; Pamela Fralick President and CEO of the Canadian Cancer Society; Carl Cadogan, CEO, Brain Tumour Foundation of Canada.

From left to right: Pamela Fralick President and CEO of the Canadian Cancer Society; Inez Jabalpurwala, President and CEO of Brain Canada; Carl Cadogan, CEO, Brain Tumour Foundation of Canada; Chris Sullivan, Board Director, Brain Tumour Foundation of Canada.

Webinar AnnouncementAzrieli Neurodevelopmental Research Program in partnership with Brain Canada

This webinar will provide information on the Azrieli Neurodevelopmental Research Program in partnership with Brain Canada (http://braincanada.ca/en/AzrieliNeurodev). It will also give an opportunity for Canadian investigators from the three Centers for Collaborative Research in Fragile-X Syndrome funded by the National Institute of Child Health and Human Development (NICHD) to cooperate and develop further international contacts and collaboration.

Follow up: To receive a copy of the webinar slideshow, or to connect with potential collaborators, please email us at programs@braincanada.ca. Note that, to connect with potential collaborators, please include a short summary of your research work and your contact information, which will be shared with interested parties.

The 2015 Multi-Investigator Research Initiative (MIRI) Sponsored Opportunity is now OPEN

Brain Canada’s MIRI grants support multidisciplinary teams for three years and usually provide up to $500,000 a year for a total of $1.5 M. The research focus may be related to any area of neural function and dysfunction, including special senses, neurological and mental health, and may involve biomedical, clinical, health services or population health approaches.

Request for Applications (RFA) announcement: December 18, 2014Deadline for Letter of Intent: 16.00 EST, February 9, 2015Click here to view the Request for Application and here to submit a Letter of Intent (LOI)

The 2015 Platform Support Grant (PSG) Sponsored Opportunity is now OPEN

Brain Canada’s PSG grants support major research platforms, local, regional or national, that provide enhanced technical and research capability to multiple investigators working in the brain sciences. Grants are for three years and maximum annual grant amounts (including matching funds) are up to $1,000,000.

The Azrieli Neurodevelopmental Research Program in partnership with Brain Canada is designed to develop new diagnostics, treatment and prevention strategies for neurodevelopmental disorders. The Azrieli Foundation will build on their prior generous investments with a $3.25M commitment, which, matched by Brain Canada, will total to $6.5M of research funding. This funding will be under Brain Canada’s Multi-Investigator Research Initiative (MIRI) or Platform Support Grants (PSGs) programs.

October 31, 2014 – Announcing our 2014 group of funded projects: Click here to view projects funded under the Multi-Investigator Research Initiative and here to view projects funded under the Platform Support Grants.

From left to right: Dr. Xiao-Yan Wen, Researcher at St. Michael’s Hospital; Dr. Arthur S. Slutsky, VP of Research at St. Michael’s Hospital; Dr. Laurie Morrison, Researcher at St. Michael’s Hospital; Dr. David Kaplan, Senior scientist at The Hospital for Sick Children and Brain Canada Board Director; Honourable Minister Rona Ambrose, Health Minister of Canada; Inez Jabalpurwala, President and CEO Brain Canada; Dr. Robert Howard, President and CEO at St. Michael’s Hospital.

Everyone at Brain Canada is deeply saddened by the recent passing of Madame Lucie Chagnon from Alzheimer’s disease, on August 17, 2014. The Chagnon Family has been profoundly touched by this devastating disease and their continued commitment to all impacted families is a source of hope and inspiration. Over the years, La Fondation Lucie et André Chagnon has also made a significant difference to the lives of young children in Quebec. This is a testament to Madame Chagnon’s lifelong dedication to her community.

Everyone at Brain Canada is deeply saddened by the death of David J. Azrieli, entrepreneur and visionary philanthropist, founder of the Azrieli Foundation. Mr. Azrieli set the example that each of us has the power to create our own narrative, and that a life filled with passion is very rich indeed. We thank him for all that he gave the world, for the legacy he built with the Azrieli Foundation, and for the lessons he shared. Through these, he will continue to influence and have impact.

From left to right: Diane Gosselin, President and CEO of CQDM; Remi Quiron, Quebec Chief Scientist; Sam David, President of the Canadian Association for Neuroscience; Inez Jabalpurwala, President and CEO of Brain Canada.

May 25th, 2014

Marcel Côté: 1942 - 2014

Everyone at Brain Canada is devastated by the sudden death of our beloved Director Marcel Côté. This is an immeasurable loss for Montreal, for Quebec and for Canada. He had the highest intelligence and integrity--but also the biggest heart. We will miss his great insights and humour--but especially his warm friendship. Our thoughts and prayers are with his family.